| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.031 | 0.5 |